30-Jan-2026
Analysts’ Top Healthcare Picks: Danaher (DHR), Palvella Therapeutics (PVLA)
TipRanks (Fri, 30-Jan 11:10 AM ET)
Analysts’ Top Healthcare Picks: Danaher (DHR), Edwards Lifesciences (EW)
TipRanks (Fri, 30-Jan 8:31 AM ET)
UBS Reaffirms Their Buy Rating on Danaher (DHR)
TipRanks (Thu, 29-Jan 9:46 AM ET)
Guggenheim Sticks to Its Buy Rating for Danaher (DHR)
TipRanks (Thu, 29-Jan 7:57 AM ET)
Analysts Are Bullish on These Healthcare Stocks: Danaher (DHR), Nurix Therapeutics (NRIX)
TipRanks (Thu, 29-Jan 7:50 AM ET)
Citi Keeps Their Buy Rating on Danaher (DHR)
TipRanks (Thu, 29-Jan 7:26 AM ET)
Danaher (DHR) Receives a Buy from Barclays
TipRanks (Thu, 29-Jan 3:27 AM ET)
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Danaher (DHR)
TipRanks (Wed, 28-Jan 11:30 PM ET)
Analysts Offer Insights on Healthcare Companies: Siegfried Holding AG (OtherSGFEF) and Danaher (DHR)
TipRanks (Wed, 28-Jan 9:10 PM ET)
Danaher Earnings Call: Cash Strength Amid Cautious Outlook
TipRanks (Wed, 28-Jan 7:24 PM ET)
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Danaher trades on the NYSE stock market under the symbol DHR.
As of January 30, 2026, DHR stock price declined to $218.89 with 5,103,891 million shares trading.
DHR has a beta of 1.02, meaning it tends to be more sensitive to market movements. DHR has a correlation of 0.28 to the broad based SPY ETF.
DHR has a market cap of $154.61 billion. This is considered a Large Cap stock.
Last quarter Danaher reported $7 billion in Revenue and $2.23 earnings per share. This beat revenue expectation by $36 million and exceeded earnings estimates by $.06.
In the last 3 years, DHR traded as high as $281.70 and as low as $171.00.
The top ETF exchange traded funds that DHR belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
DHR has underperformed the market in the last year with a price return of -1.6% while the SPY ETF gained +16.2%. However, in the short term, DHR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +2.4% vs +1.0% return in SPY. But in the last 2 weeks, DHR shares have been beat by the market, returning -8.8% compared to an SPY return of 0.0%.
DHR support price is $216.13 and resistance is $223.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DHR shares will trade within this expected range on the day.